Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1980 Apr;43(4):490–491. doi: 10.1136/hrt.43.4.490

Papilloedema and hepatic dysfunction apparently induced by perhexiline maleate (Pexid).

A B Atkinson, D McAreavey, G Trope
PMCID: PMC482324  PMID: 7397053

Abstract

A patient developed papilloedema and hepatic dysfunction while being treated with perhexiline maleate. These later regressed when the drug was withdrawn. Patients should be monitored for these potentially serious side-effects while on this drug.

Full text

PDF
490

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bousser M. G., Bouche P., Brochard C., Herreman G. Neuropathies périphériques au maléate de perhexiline. A propos de 7 observations. Coeur Med Interne. 1976 Apr-Jun;15(2):181–188. [PubMed] [Google Scholar]
  2. Hutchinson W. M., Williams J., Gawler J. Papilloedema in patients taking perhexiline maleate. Br Med J. 1978 Feb 4;1(6108):305–305. doi: 10.1136/bmj.1.6108.305-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Stephens W. P., Eddy J. D., Parsons L. M., Singh S. P. Raised intracranial pressure due to perhexiline maleate. Br Med J. 1978 Jan 7;1(6104):21–21. doi: 10.1136/bmj.1.6104.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Tomlinson I. W., Rosenthal F. D. Proximal myopathy after perhexiline maleate treatment. Br Med J. 1977 May 21;1(6072):1319–1320. doi: 10.1136/bmj.1.6072.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES